Logo image of ROMA

ROMA GREEN FINANCE LTD (ROMA) Stock Fundamental Analysis

NASDAQ:ROMA - Nasdaq - KYG7633Y1089 - Common Stock - Currency: USD

2.9093  -0.37 (-11.34%)

After market: 2.9301 +0.02 (+0.71%)

Fundamental Rating

3

Taking everything into account, ROMA scores 3 out of 10 in our fundamental rating. ROMA was compared to 83 industry peers in the Commercial Services & Supplies industry. While ROMA has a great health rating, there are worries on its profitability. ROMA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year ROMA has reported negative net income.
ROMA had a negative operating cash flow in the past year.
ROMA Yearly Net Income VS EBIT VS OCF VS FCFROMA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -5M -10M -15M -20M -25M

1.2 Ratios

ROMA's Return On Assets of -34.80% is on the low side compared to the rest of the industry. ROMA is outperformed by 89.16% of its industry peers.
ROMA has a Return On Equity of -39.19%. This is in the lower half of the industry: ROMA underperforms 77.11% of its industry peers.
Industry RankSector Rank
ROA -34.8%
ROE -39.19%
ROIC N/A
ROA(3y)-17.27%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROMA Yearly ROA, ROE, ROICROMA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 100 -100 200

1.3 Margins

With a Gross Margin value of 25.27%, ROMA is not doing good in the industry: 63.86% of the companies in the same industry are doing better.
ROMA's Gross Margin has declined in the last couple of years.
ROMA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.13%
GM growth 5YN/A
ROMA Yearly Profit, Operating, Gross MarginsROMA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

9

2. Health

2.1 Basic Checks

ROMA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ROMA has about the same amount of shares outstanding.
ROMA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ROMA Yearly Shares OutstandingROMA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M 10M
ROMA Yearly Total Debt VS Total AssetsROMA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

ROMA has an Altman-Z score of 21.49. This indicates that ROMA is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 21.49, ROMA belongs to the top of the industry, outperforming 97.59% of the companies in the same industry.
There is no outstanding debt for ROMA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 21.49
ROIC/WACCN/A
WACC10.11%
ROMA Yearly LT Debt VS Equity VS FCFROMA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

ROMA has a Current Ratio of 8.54. This indicates that ROMA is financially healthy and has no problem in meeting its short term obligations.
ROMA's Current ratio of 8.54 is amongst the best of the industry. ROMA outperforms 98.80% of its industry peers.
A Quick Ratio of 8.54 indicates that ROMA has no problem at all paying its short term obligations.
ROMA has a better Quick ratio (8.54) than 98.80% of its industry peers.
Industry RankSector Rank
Current Ratio 8.54
Quick Ratio 8.54
ROMA Yearly Current Assets VS Current LiabilitesROMA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M 50M

0

3. Growth

3.1 Past

The earnings per share for ROMA have decreased strongly by -948.29% in the last year.
The Revenue for ROMA has decreased by -30.14% in the past year. This is quite bad
The Revenue for ROMA have been decreasing by -10.20% on average. This is quite bad
EPS 1Y (TTM)-948.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1214.26%
Revenue 1Y (TTM)-30.14%
Revenue growth 3Y-10.2%
Revenue growth 5YN/A
Sales Q2Q%-37.58%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ROMA Yearly Revenue VS EstimatesROMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 5M 10M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ROMA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ROMA Price Earnings VS Forward Price EarningsROMA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ROMA Per share dataROMA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ROMA!.
Industry RankSector Rank
Dividend Yield N/A

ROMA GREEN FINANCE LTD

NASDAQ:ROMA (6/27/2025, 8:00:02 PM)

After market: 2.9301 +0.02 (+0.71%)

2.9093

-0.37 (-11.34%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.97%
Inst Owner Change-15.76%
Ins Owners50.74%
Ins Owner ChangeN/A
Market Cap34.80M
AnalystsN/A
Price TargetN/A
Short Float %1.63%
Short Ratio0.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 20.89
P/FCF N/A
P/OCF N/A
P/B 4.62
P/tB 4.62
EV/EBITDA N/A
EPS(TTM)-0.28
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS0.14
BVpS0.63
TBVpS0.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -34.8%
ROE -39.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.27%
FCFM N/A
ROA(3y)-17.27%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.13%
GM growth 5YN/A
F-Score3
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.54
Quick Ratio 8.54
Altman-Z 21.49
F-Score3
WACC10.11%
ROIC/WACCN/A
Cap/Depr(3y)122.78%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.2%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-948.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1214.26%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.14%
Revenue growth 3Y-10.2%
Revenue growth 5YN/A
Sales Q2Q%-37.58%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-655.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-43334.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-143675%
OCF growth 3YN/A
OCF growth 5YN/A